- Implantable Pacemaker
- External Pacemaker
Cardiac Pacemakers Market size was valued at USD 4,446.2 million in 2022 and is poised to grow at a CAGR of 5.6% from 2023-2029. pacemaker is a small device that is placed in the abdomen or chest that helps in controlling abnormal rhythms of the heart. Pacemakers use low-energy electrical pulses to prompt the heart beat at a normal rate. Pacemakers are used in the treatment of arrhythmias. Increase in prevalence of heart diseases worldwide boosting Cardiac Pacemakers market globally. According to the WHO, cardiovascular disease is one of the leading causes of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012 In addition, the increase in demand for invasive techniques in the treatment of heart diseases and lifestyle changes bolstered the Cardiac Pacemakers market. Furthermore, technological advancements and adaptability are expected to boost the market growth. However, certain risks in Cardiac Pacemakers such as infection at the surgical site, failure to deliver optimum therapy when needed (either extra therapy when it is not needed or no therapy delivered when it is needed), and sensitivity to the device material are hampering the Cardiac Pacemakers market. Many countries have endured and continue to incur severe economic and healthcare burdens as a result of the high transmission rate and lack of treatment. Many governments have gone into lockdown, suspending trade with other countries, imposing travel restrictions, and so on, causing large firms' market capitalizations to plummet around the world.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The market for cardiac pacemaker devices is being driven by the rising prevalence of cardiovascular disorders such as bradycardia and tachycardia, as well as rising life expectancy, obesity, sedentary lifestyles, alcohol use and technical improvements. Clinicians can now give creative approaches to care for the elderly population thanks to advances in technology and engineering. Low-power circuits, high-density batteries, and new software designs have fueled a series of game-changing advancements in cardiac pacing in particular over the last few years.
The Cardiac Pacemakers Market Size was valued at USD 4,446.2 million in 2022
The Cardiac Pacemakers Market Key Players are Abbott Laboratories (U.S.) Medtronic plc (U.S.) Osypka Medical, Inc (Germany) BIOTRONIK SE & Co. KG (Germany) Boston Scientific Corporation (U.S.) OSCOR Inc. (U.S.) Medico S.p.A. (Italy) Lepu Medical Technology Co ltd.(China)
Asia Pacific is the fastest region for the Cardiac Pacemakers Market
1.Executive Summary |
2.Global Cardiac Pacemakers Market Introduction |
2.1.Global Cardiac Pacemakers Market - Taxonomy |
2.2.Global Cardiac Pacemakers Market - Definitions |
2.2.1. By Type |
2.2.2. By Technology |
2.2.3. By End Users |
2.2.4. By Region |
3.Global Cardiac Pacemakers Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Cardiac Pacemakers Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Cardiac Pacemakers Market By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Implantable pacemaker |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. External Pacemaker |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Cardiac Pacemakers Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Single Chambered |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biventricular |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Dual Chambered |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Cardiac Pacemakers Market By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Ambulatory Surgical Centers |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Hospitals |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Clinics |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Cardiac Pacemakers Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Cardiac Pacemakers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Implantable pacemaker |
9.1.2.External Pacemaker |
9.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Single Chambered |
9.2.2.Biventricular |
9.2.3.Dual Chambered |
9.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Ambulatory Surgical Centers |
9.3.2.Hospitals |
9.3.3.Clinics |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Cardiac Pacemakers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Implantable pacemaker |
10.1.2.External Pacemaker |
10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Single Chambered |
10.2.2.Biventricular |
10.2.3.Dual Chambered |
10.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Ambulatory Surgical Centers |
10.3.2.Hospitals |
10.3.3.Clinics |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Cardiac Pacemakers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Implantable pacemaker |
11.1.2.External Pacemaker |
11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Single Chambered |
11.2.2.Biventricular |
11.2.3.Dual Chambered |
11.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Ambulatory Surgical Centers |
11.3.2.Hospitals |
11.3.3.Clinics |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Cardiac Pacemakers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Implantable pacemaker |
12.1.2.External Pacemaker |
12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Single Chambered |
12.2.2.Biventricular |
12.2.3.Dual Chambered |
12.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Ambulatory Surgical Centers |
12.3.2.Hospitals |
12.3.3.Clinics |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Cardiac Pacemakers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Implantable pacemaker |
13.1.2.External Pacemaker |
13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Single Chambered |
13.2.2.Biventricular |
13.2.3.Dual Chambered |
13.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Ambulatory Surgical Centers |
13.3.2.Hospitals |
13.3.3.Clinics |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Abbott Laboratories (U.S.) |
14.2.2.Medtronic plc (U.S.) |
14.2.3.Osypka Medical, Inc (Germany) |
14.2.4.BIOTRONIK SE & Co. KG (Germany) |
14.2.5.Boston Scientific Corporation (U.S.) |
14.2.6.OSCOR Inc. (U.S.) |
14.2.7.Lepu Medical Technology Co ltd.(China) |
14.2.8.SORIN Group (U.S.) |
14.2.9.Pacetronix ltd.(India) |
15. Research Methodology |
16. Appendix and Abbreviations |